期刊文献+

注射用灯盏花素脂质体在Beagle犬体内的药代动力学 被引量:17

Pharmacokinetics of breviscapine liposomes following intravenous injection in Beagle dogs
下载PDF
导出
摘要 目的制备灯盏花素脂质体,研究灯盏花素脂质体在Beagle犬体内的药代动力学。方法采用双周期交叉试验法,6只Beagle犬分别单剂量(以灯盏乙素计为28mg/只)静脉注射自制灯盏花素脂质体和市售普通注射液,用反相高效液相色谱法测定不同时间血浆中灯盏乙素的浓度,采用3P97计算药代动力学参数,并进行统计学分析。结果脂质体和市售注射液的T1/2α分别为(4·4±0·7)min和(1·8±1·3)min;T1/2β分别为(55±27)min和(28±23)min;Vc分别为(1580±265)mL和(2460±2200)mL;CLs分别为(88±10)mL·min-1和(324±69)mL·min-1;AUC0-720分别为(363±42)μg·min·mL-1和(102±19)μg·min·mL-1。两种制剂的T1/2α,CLs及AUC0-720经方差分析后均存在极显著或显著性差异。结论与市售普通注射液相比,灯盏花素脂质体Beagle犬静脉注射给药后,大大提高了血药浓度,显著改善了灯盏乙素原药的药代动力学性质,具有缓释作用。 Aim To prepare the breviscapine liposomes and study the pharmacokinetics of breviscapine liposomes in Beagle dogs. Methods The cross-over design (two periods) was employed. Six Beagle dogs were administrated a single intravenous dosage of 28 mg of breviscapine liposomes and reference preparation, respectively, scutellarin in plasma of 6 dogs at different sampling time was determined by RP-HPLC. The pharmacokinetic parameters were calculated by 3P97 program and compared by statistic analysis. Results The mean concentration-time curves of breviscapine liposomes and reference preparation were both fitted to two-compartment model with the main pharmacokinetic parameters as follows: T1/2α were (4. 4 ± 0.7 ) min and ( 1.8 ± 1.3 ) min respectively ; T1/2α were ( 55 ± 27 ) min and (28 ± 23 ) min respectively ; Vc were ( 1 580 ± 265 ) mL and (2 460 ± 2 200) mL respectively ; CLs were (88 ± 10) mL ·min^-1 and (324 ±69) mL ·min^-1 respectively; and AUC0-720 were (363 ±42)μg·min·mL^-1 and ( 102 ± 19) μg·min·mL^-1 respectively. The Ti/2α, CLs and AUC0-720 of breviscapine liposomes all had significant difference from those of reference preparation, after the data were examined by a one-way analysis of variance (ANOVA). Conclusion Compared with the reference preparation, breviscapine liposomes had a much more higher concentration in plasma and contained characteristic of sustained-release, which ameliorated the pharmacokinetic properties of scutellarin.
出处 《药学学报》 CAS CSCD 北大核心 2006年第1期24-29,共6页 Acta Pharmaceutica Sinica
基金 国家高技术研究发展计划(863计划)重大科技专项资助(2004AA2Z3230) 江苏省自然科学基金重点项目资助(BK2001210)
关键词 灯盏花素 灯盏乙素 脂质体 药代动力学 反相高效液相色谱法 breviscapine scutellarin liposome pharmacokinetics RP-HPLC
  • 相关文献

参考文献6

二级参考文献16

  • 1蒋学华,李素华,兰轲,杨俊毅,周静.灯盏花素在家犬体内的药代动力学[J].药学学报,2003,38(5):371-373. 被引量:67
  • 2徐庆有,李学信.灯盏细辛注射液对高粘滞血症病人血液粘度的影响[J].新药与临床,1995,14(4):233-234. 被引量:77
  • 3冯年平,屠锡德.盐酸拉贝洛尔缓释片及其药动学研究[J].中国药科大学学报,1996,27(1):13-15. 被引量:5
  • 4顾天华(Gu TH) 顾德官(Gu DG).柳胺苄心啶的临床和毒理进展[J].中国新药与临床杂志(Chin J New Drugs Chin Rem),1984,3(3):28-30.
  • 5[1]Chen XQ, Jin YY. The New Edition of Medicaments (新编药物学) [M]. 14th Ed. Beijing: People's Medical Publishing House, 1997.277-278.
  • 6[2]Xu QY, Li XX. Influences of Dengzhan Xixin injection on blood viscosity in patients with high blood viscosity [J]. Chin J New Drugs Clin Rem(中国新药与临床杂志), 1995,14(4):233-235.
  • 7[3]Xu JM, Huang ZH. DengZhan XiXin capsules in the treatment of cerebrovascular disorders in 74 patients [J]. Chin J New Drugs Clin Rem(中国新药与临床杂志), 1991,10(5):260-263.
  • 8[4]Department of Chinese Tradititional Medicine and Herbal Drugs, State Drug Administration. Handbook of Active Ingredients of Phytomedicines (植物药有效成分手册) [Z]. Beijing: People's Medical Publishing House, 1986.946-947.
  • 9汪明性.新编实用药物学[M].北京:科学出版社,2000.277.
  • 10莫韫,张钧寿.结肠靶向给药系统研究进展[J].中国新药杂志,1999,8(6):368-371. 被引量:24

共引文献176

同被引文献228

引证文献17

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部